- Home
- RDUS vs TRVI Comparison
RDUS vs TRVI Comparison
Compare RDUS & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDUS
- TRVI
- Stock Information
- Founded
- RDUS 1906
- TRVI 2011
- Country
- RDUS United States
- TRVI United States
- Employees
- RDUS N/A
- TRVI N/A
- Industry
- RDUS Industrial Specialties
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- RDUS Consumer Discretionary
- TRVI Health Care
- Exchange
- RDUS Nasdaq
- TRVI Nasdaq
- Market Cap
- RDUS 816.4M
- TRVI 383.4M
- IPO Year
- RDUS 1993
- TRVI 2019
- Fundamental
- Price
- RDUS $29.38
- TRVI $6.60
- Analyst Decision
- RDUS Hold
- TRVI Strong Buy
- Analyst Count
- RDUS 2
- TRVI 8
- Target Price
- RDUS $22.00
- TRVI $17.56
- AVG Volume (30 Days)
- RDUS 760.1K
- TRVI 1.3M
- Earning Date
- RDUS 07-01-2025
- TRVI 05-08-2025
- Dividend Yield
- RDUS 2.55%
- TRVI N/A
- EPS Growth
- RDUS N/A
- TRVI N/A
- EPS
- RDUS N/A
- TRVI N/A
- Revenue
- RDUS $2,743,781,000.00
- TRVI N/A
- Revenue This Year
- RDUS $2.35
- TRVI N/A
- Revenue Next Year
- RDUS $7.03
- TRVI N/A
- P/E Ratio
- RDUS N/A
- TRVI N/A
- Revenue Growth
- RDUS N/A
- TRVI N/A
- 52 Week Low
- RDUS $10.57
- TRVI $2.30
- 52 Week High
- RDUS $29.48
- TRVI $7.39
- Technical
- Relative Strength Index (RSI)
- RDUS 74.94
- TRVI 56.08
- Support Level
- RDUS $29.29
- TRVI $6.14
- Resistance Level
- RDUS $29.48
- TRVI $7.24
- Average True Range (ATR)
- RDUS 0.23
- TRVI 0.39
- MACD
- RDUS -0.29
- TRVI 0.01
- Stochastic Oscillator
- RDUS 85.07
- TRVI 50.39
About RDUS Schnitzer Steel Industries Inc.
Radius Recycling Inc is a North American Based company which is involved in recycling of ferrous and nonferrous metal, including end-of-life vehicles, and a manufacturer of finished steel products. As a vertically integrated organization, it offers products and services to meet world-wide demand through the network that includes fifty retail self-service auto parts stores, fifty four metals recycling facilities, and an electric arc furnace steel mill.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.